Skip to main content

LifeVantage Corporation

corporate_fare Company Profile

LifeVantage Corporation

LFVN·NASDAQ·Life Sciences·CIK 0000849146

Lifevantage Corp is a company focused on nutrigenomics, which is the study of how nutrition and naturally occurring compounds affect human genes to support good health. The company identifies, researches, develops, formulates, and sells advanced nutrigenomic activators, dietary supplements, weight management products, gut health products, skin and hair care products, and nootropics. LifeVantage provides these scientifically validated products to customers and independent consultants, offering a commission-based direct sales opportunity to its independent consultants. The company's product lines include Protandim®, its flagship line of scientifically validated dietary supplements. The LifeVantage® line encompasses dietary supplements such as the MindBody GLP-1 System®, Omega+, ProBio, IC Bright®, the Rise AM & Reset PM System®, D3+, Daily Wellness, Fat Burn, Prebiotic, and Carb Block. TrueScience® is LifeVantage's line of skin and hair care products and Liquid Collagen. The P84 System is a newer activator designed to regulate, repair, and restore gut health. Petandim® is a companion pet supplement formulated to combat oxidative stress in dogs. AXIO® consists of nootropic and energy/hydration drink mixes. LifeVantage sells its products in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, Iceland, and Portugal. The company also sells products to customers for personal consumption only in a number of other countries. LifeVantage was incorporated in Colorado in June 1988 as Andraplex Corporation, undergoing several name changes before becoming LifeVantage Corporation in November 2006. From fiscal year 2005 to fiscal year 2009, the company marketed and sold Protandim® through traditional retail stores.

LifeVantage Corporation (NASDAQ:LFVN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for LFVN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for LFVN spans 10-Q, 8-K, 10-K, 4.

Recent high-impact activity:

  • LifeVantage Swings to $196K Q1 Loss as Revenue Falls 22% to $37.1M
  • LifeVantage Q1 Revenue Slides to $37.1M as Sales Slump Persists
  • LifeVantage Q4 Revenue Falls 23% as Active Accounts Shrink 21%; FY27 Guidance Withheld
  • LifeVantage FY2026 10-K: Revenue Falls 20%, Active Accounts Drop 21%, New CEO and $60M Buyback Authorized
  • LifeVantage Q4 Revenue Plunges 23% as Active Accounts Shrink 21%

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$182.59M
Net Income
$5.07M
Diluted EPS
$0.40
Op. Cash Flow
$10.24M
Free Cash Flow
$6.67M
Gross Profit
$141.61M
Operating Income
$6.1M
Cash & Equivalents
$14.92M
Debt / Equity
0.00×
Net Margin
2.8%
Shares Outstanding
12.52M sh
Source: 10-K · filed 2026-08-27 · accession 0001193125-26-371257

Short Interest & Short Volume

42.11 days to cover

FINRA reported short interest of 906,622 shares in LFVN as of the October 30, 2026 settlement, a 7.1% decrease from the prior period — about 42.1 days to cover at its recent average daily volume. On November 20, 2026, 40.5% of LFVN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)906,622 shares as of October 30, 2026
Change vs prior period▼ 7.1%
Days to cover42.11 at avg daily volume of 21,530
Daily short volume (FINRA facilities)40.5% of 28,654 shares on November 20, 2026
5-day average short volume28.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with L →
$4.89
52-week range · as of 2026-11-09 $3.9 – $11.71
Market cap
$52.63M
Volume
72.9K (1.5× avg)
3-mo avg 48.3K
Live data · 2026-11-21 19:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LFVN - Latest Insights

LFVN
Nov 09, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.01
Real-time Price: $4.89 info
Change: -$0.120 (-2%) info
Market Cap: $52.631M info
LFVN
Nov 09, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.01
Real-time Price: $4.89 info
Change: -$0.120 (-2%) info
Market Cap: $52.631M info
LFVN
Aug 27, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.45
Real-time Price: $4.89 info
Change: -$1.56 (-24%) info
Market Cap: $52.631M info
LFVN
Aug 27, 2026, 4:05 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $6.45
Real-time Price: $4.89 info
Change: -$1.56 (-24%) info
Market Cap: $52.631M info
LFVN
Aug 27, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.45
Real-time Price: $4.89 info
Change: -$1.56 (-24%) info
Market Cap: $52.631M info
LFVN
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $4.89 info
Change: -$0.010 (-0.20%) info
Market Cap: $52.631M info
LFVN
May 06, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $4.89 info
Change: -$0.0109 (-0.22%) info
Market Cap: $52.631M info
LFVN
May 06, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $5.14
Real-time Price: $4.89 info
Change: -$0.250 (-5%) info
Market Cap: $52.631M info
LFVN
Apr 21, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $4.89 info
Change: -$0.360 (-7%) info
Market Cap: $52.631M info
LFVN
Apr 16, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.57
Real-time Price: $4.89 info
Change: +$0.320 (+7%) info
Market Cap: $52.631M info
LFVN
Apr 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $4.89 info
Change: +$0.690 (+16%) info
Market Cap: $52.631M info
LFVN
Mar 02, 2026, 6:44 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $4.64
Real-time Price: $4.89 info
Change: +$0.250 (+5%) info
Market Cap: $52.631M info
LFVN
Feb 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $4.89 info
Change: +$1.11 (+29%) info
Market Cap: $52.631M info
LFVN
Feb 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $4.89 info
Change: +$1.11 (+29%) info
Market Cap: $52.631M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets